Skip to content
TTM Q3 '26TTM Q2 '26TTM Q1 '26TTM Q4 '25TTM Q3 '25
-$143.89M-66.9%-$131.48M-49.4%-$119.32M-31.2%-$113.81M-20.9%-$86.23M
$8.22M-8.9%$8.13M-18.9%$7.62M-31.0%$7.97M-31.1%$9.02M
$45.65M+1,859%$36M+1,505%$28.47M+1,807%$24.27M+1,531%$2.33M
-$87.04M-21.5%-$86.67M-20.9%-$86.38M-20.5%-$77.61M-7.4%-$71.61M
$32.62M+75.3%$26.88M+52.8%$24.07M+48.5%$22.94M+87.6%$18.6M
-$37.98M-100%-$27.51M-56.6%-$24.51M-51.2%-$23.31M-90.6%-$18.96M
$361.98M
$236.97M
-$119.66M-32.6%-$113.55M-27.2%-$110.45M-25.7%-$100.54M-19.0%-$90.21M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Kestra Medical Technologies, Ltd. Common Stock generate?
Kestra Medical Technologies, Ltd. Common Stock (KMTS) generated -$87.0M in operating cash flow over the trailing twelve months.
What is Kestra Medical Technologies, Ltd. Common Stock's free cash flow?
After $32.6M of capital expenditures, Kestra Medical Technologies, Ltd. Common Stock's free cash flow was -$119.7M over the trailing twelve months, down 32.6% year over year.
Where does Kestra Medical Technologies, Ltd. Common Stock's cash flow data come from?
Every line is extracted from Kestra Medical Technologies, Ltd. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.